Abstract Submissions
Satellite Symposia
Enduring Activity

Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 26.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 26.0 Contact Hours.

Mini Symposium: Earn up to 5.0 AMA PRA Category 1 Credits™ (5.0 Contact Hours)

Main Conference: Earn up to 21.0 AMA PRA Category 1 Credits™ (21.0 Contact Hours)

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc.; Athenex; AstraZeneca; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai Inc.; Genentech; Genomic Health, Inc.; KCI USA, Inc.; MacroGenics, Inc.; Merck Sharp & Dohme Corp; Novartis Pharmaceuticals Corporation; Pacira Pharmaceuticals, Inc.; Pfizer; Puma Biotechnology, Inc.; and Seattle Genetics, Inc.

37th Annual Miami Breast Cancer Conference®

37th Annual Miami Breast Cancer Conference®

Register for 2021

Fontainebleau Miami Beach
4441 Collins Avenue
Miami Beach, FL 33140

The Conference will go on as scheduled!

Physicians’ Education Resource®, LLC, understands the concerns surrounding the outbreak and spread of the coronavirus (COVID-19) currently affecting several countries. After monitoring the situation and information being shared by the CDC, and taking into account current travel restrictions, we have decided that the 37th Annual Miami Breast Cancer Conference® will go on as scheduled. Be assured that there is nothing more important to us than the safety of our participants; therefore, we have worked with our host hotel and taken steps to implement additional precautions on-site to keep our attendees safe at this year’s conference. We look forward to seeing you there.

37th Annual Miami Breast Cancer Conference® Overview

Breast cancer represents a complicated family of diseases for which detection, diagnosis, and multimodal management strategies are continually evolving. With each lesson learned about the biology of these diseases and with each improvement to the standards of care, new questions, challenges, and controversies arise. Therefore, practice-focused education that enables you to integrate the highest-quality methodologies into your clinic is essential. For 37 years, the multidisciplinary Miami Breast Cancer Conference® has met this educational need—bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists—to improve the care received by patients with breast cancer.

In March 2020, the 37th Annual Miami Breast Cancer Conference® will continue this tradition and feature the innovative programming and top-notch presentations for which this conference is known. This year’s program will feature world-class tumor board panels, multidisciplinary meet-the-experts small-group breakout sessions, poster talks, a patient-communication workshop, and more time for networking in the afternoons. Topics on the agenda include contemporary management issues, physician burnout, evidence-based alternative medicine, real-world outcomes, treatment de-escalation, patient-centered care, and much, much more. Please join us at the 37th Annual Miami Breast Cancer Conference®. Register today!

Hear it on Friday, use it on Monday

Benefits of Attending the 37th Annual Miami Breast Cancer Conference®

  • Network with your peers and world-renowned thought leaders
  • Ask world-renowned thought leaders your important questions
  • Apply the latest evidence, therapies, and strategies in your practice
  • Gain expert perspectives and clarity on areas of clinical uncertainty and controversy
  • Improve the patient-centered, state-of-the-art care you provide to your patients

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other healthcare professionals interested in the treatment of breast cancer are also invited to attend.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc.; Athenex; AstraZeneca; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai Inc.; Genentech; Genomic Health, Inc.; KCI USA, Inc.; MacroGenics, Inc.; Merck Sharp & Dohme Corp; Novartis Pharmaceuticals Corporation; Pacira Pharmaceuticals, Inc.; Pfizer; Puma Biotechnology, Inc.; and Seattle Genetics, Inc.

Learning Objectives

  • Incorporate evidence-based molecular and genomic biomarkers, multi-gene prognostic assays, and tumor subtype information, as appropriate to guide clinical decision-making and optimize outcomes for individual patients
  • Summarize expert guidelines and evidence from clinical trials that supports the use of genomic and molecular tools to individualize and inform treatment decisions for patients with breast cancer
  • Implement evidence-based multimodal treatment strategies, integrating surgery, radiation, and systemic therapy when appropriate, to ensure optimal outcomes for patients with non-metastatic breast cancer
  • Coordinate a multidisciplinary approach to prevent, mitigate, or manage treatment-related adverse events for patients with breast cancer to optimize outcomes
  • Integrate recent clinical trial data and expert guidelines regarding systemic therapies into treatment planning in order to provide evidence-based state-of-the-art care for patients with breast cancer
  • Identify ongoing clinical trials of emerging agents and strategies that offer additional treatment options for patients with breast cancer

Program Chair

Patrick I. Borgen
Patrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Brooklyn, NY

Program Co-Chairs

Anees B. Chagpar
Anees B. Chagpar, MD, MSc, MPH, MA, MBA, FACS, FRCS(C)
Professor of Surgery (Oncology)
Assistant Director, Global Oncology
Yale Comprehensive Cancer Center
New Haven, CT
Hope S. Rugo
Hope S. Rugo, MD, FASCO
Professor of Medicine
Director of Breast Oncology and Clinical Trials Education
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Debu Tripathy
Debu Tripathy, MD
Professor and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX


The Miami Breast Cancer Conference® mini-symposium offers an additional educational opportunity for attendees who plan to arrive in Miami the day before the official conference begins. The mini-symposium takes the format of a world-class tumor board, featuring cases and discussions that highlight challenging clinical situations commonly faced by surgeons and oncologists. This special session was developed to be of interest to healthcare practitioners from all specialties and will provide practical information to enhance patient care in the clinic, delivered by top experts in the field of breast cancer. If your schedule allows, we hope you will plan to attend and take advantage of this extra session!

Note: Separate registration is required.


Registration Fees

Mini Symposium* &
Main Conference
March 5 - 8, 2020
Main Conference Only
March 6 - 8, 2020
Nurses, PAs, Other Health Care Professionals
Guest (access to receptions only)*

*Discount does not apply to the mini-symposium or guest registration.
**FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount.
***INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email info@gotoper.com or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested through and including January 25, 2020, and a 50% fee on refunds requested on January 26, 2020, through February 22, 2020. No refunds will be made after February 22, 2020. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians’ Education Resource®, LLC (PER®), fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians’ Education Resource®, LLC, reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

By attending a PER® conference, meeting or related activity (“Events”), all participants, attendees, exhibitors, sponsors, and guests (“you”) create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness (“Image”).  By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19

I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventive measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities, including providing proof at check in of being 2 weeks removed from receiving a full COVID-19 vaccination or results from a negative COVID-19 viral test taken no more than 3 days prior to the program.

I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.

* By checking this box, you have read and understand the above and agree to its terms.

Calendar of Events
Filter By